APH vs SOLV · P/E 40, rev $23.09B vs P/E 9.1, rev $8.25B
Amphenol Corporation (APH) versus Solventum Corp. (SOLV) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
Solventum Corp. (SOLV) is a medical instruments & supplies company listed on NYSE.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported SOLV revenue for 2024-12-31 was $8.25B. Net income was $479.0M. Revenue was up 0.7% from 2023-12-31 to 2024-12-31. SOLV currently screens at market cap $12.91B and trailing P/E 9.1.
APH currently screens at market cap $170.77B and trailing P/E 39.9. SOLV currently screens at market cap $12.91B and trailing P/E 9.1.
Not investment advice. Open the APH and SOLV stock pages for the full models.
Not investment advice.